Eragon Family Office

Eragon Ventures is a single family office established by the former promoters of J.B. Chemicals and Pharmaceuticals. The firm is dedicated to investing long-term patient capital across various asset classes, aiming to support founders at different stages of their entrepreneurial journey. Their investment philosophy is rooted in the family's values, risk appetite, and a commitment to sustainable wealth preservation and growth.

The firm was founded in 2021 by Pranabh Mody, following the sale of J.B. Chemicals and Pharmaceuticals to KKR in 2020. Eragon Ventures' mission is to ethically and sustainably grow the family's wealth and legacy through strategic investment decisions. They actively seek to partner with companies that add value to India and its people, believing strongly in the entrepreneurial talent fostered within the country.

Eragon Ventures focuses its investments primarily in the Healthtech, Sustainability, and Technology sectors. Their portfolio includes companies like Dozee (continuous patient monitoring with AI), Veeda Life Sciences (CRO with AI for drug discovery), I2Pure (molecular Iodine healthcare solutions), OneCell.Ai (AI-based cancer diagnostics), Neural Hive Technologies (AI for digital dentistry), Partex (AI for pharmaceutical asset monetization), Galaxeye (multi-sensor imaging satellites), Leverage Edu (Edtech), and Hosteller (backpacking hostels in India). The firm emphasizes a flexible and dynamic approach, not being bound by conventional deal and fund structures, and provides strategic resources to its portfolio companies.

The leadership team at Eragon Ventures includes Pranabh Mody as Managing Director, who oversees investments across various asset classes. Sharan Asher serves as Director, with a particular focus on Private Equity and Venture Capital. Shivani Vishwanathan heads listed equities research, and Devendra Khedekar manages Finance, Accounting, and Operations, bringing extensive experience from J.B. Chemicals and Pharmaceuticals.